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Abstract: Myelinated Schwann cells in the peripheral nervous system express the p75 nerve growth factor receptor (p75NGFR) 
as a consequence of Schwann cell dedifferentiation during Wallerian degeneration. p75NGFR has been implicated in the 
remyelination of regenerating nerves. Although many studies have shown various mechanisms underlying Schwann cell 
dedifferentiation, the molecular mechanism contributing to the re-expression of p75NGFR in differentiated Schwann cells is 
largely unknown. In the present study, we found that lysosomes were transiently activated in Schwann cells after nerve injury 
and that the inhibition of lysosomal activation by chloroquine or lysosomal acidification inhibitors prevented p75NGFR 
expression at the mRNA transcriptional level in an ex vivo Wallerian degeneration model. Lysosomal acidification inhibitors 
suppressed demyelination, but not axonal degeneration, thereby suggesting that demyelination mediated by lysosomes may be 
an important signal for inducing p75NGFR expression. Tumor necrosis factor-α (TNF-α) has been suggested to be involved 
in regulating p75NGFR expression in Schwann cells. In this study, we found that removing TNF-α in vivo did not significantly 
suppress the induction of both lysosomes and p75NGFR. Thus, these findings suggest that lysosomal activation is tightly 
correlated with the induction of p75NGFR in demyelinating Schwann cells during Wallerian degeneration. 
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in degenerating peripheral nerves [1]. During myelin 
removal in Schwann cells, the cells begin to acquire several 
macrophage-like phenotypes [1]. The galactose-specific 
lectin, MAC-2, and the A1 antigen, a macrophage marker, 
are strongly expressed in Schwann cells during the early 
stages of Wallerian degeneration, and inhibition of MAC-2 
prevents myelin removal by Schwann cells [2]. Furthermore, 
demyelination mediated through Schwann cells is enhanced 
by the lysosomal pathways [3, 4]. Lysosomes contain many 
hydrolytic enzymes that participate in degrading myelin lipids 
and proteins. Studies utilizing enzymatic histochemistry have 
reported that the number of lysosomes and the activity of 
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Wallerian degeneration of nerves occurs in the distal 
segment of lesion sites after injury. Both Schwann cells 
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lysosomal enzymes increase in Schwann cells within 1 week 
after injury [4, 5]. We recently reported that the protein levels 
of lysosomal associated membrane protein 1 (LAMP1), a 
lysosomal membrane marker, increase dramatically in sciatic 
nerves following injury [6]. 
Axonal signaling molecules such as neuregulin and 
neurotrophic factors regulate remyelination by Schwann 
cells during peripheral nerve regeneration [7-10]. A 
growing body of evidence suggests that signal transduction 
mediated by nerve growth factor (NGF) and brain-derived 
neurotrophic factor via the p75 NGF receptor (p75NGFR) 
plays a role in the myelination process [8, 11]. p75NGFR 
is normally expressed in non-myelinated Schwann cells of 
uninjured nerves, but peripheral nerve injury rapidly induces 
p75NGFR in demyelinating myelinated Schwann cells [12, 
13]. p75NGFR-null mice exhibit impaired remyelination after 
sciatic nerve injury, thereby suggesting a role for p75NGFR 
in remyelination in vivo [14, 15]. Derepression through the 
loss of axonal signals may result in p75NGFR induction in 
demyelinating Schwann cells after injury [16]. However, 
the mechanism by which axonal injury regulates p75NGFR 
induction in Schwann cells is not well understood. In addition 
to the loss of axonal signals, demyelination after nerve injury 
may also involve p75NGFR expression in Schwann cells. 
For example, the demyelinating agent, lysolecithin, induces 
p75NGFR expression in Schwann cells [17]. Furthermore, 
several in vitro studies have shown the involvement of 
tumor necrosis factor-α (TNF-α) in p75NGFR expression 
in Schwann cells [18-20]. In the present study, we examined 
whether lysosomal activation, which is a well-characterized 
mediator of demyelination, is associated with p75NGFR 
induction in Schwann cells.
Materials and Methods
Animal surgery
The adult mice (C57BL6) sciatic nerve crush injury model 
was used as previously described [21, 22]. All procedures 
were performed according to protocols approved by the 
Dong-A University committee on animal research, which 
followed the guidelines for animal experiments established by 
the Korean Academy of Medical Sciences. Briefly, the sciatic 
nerve was exposed at the mid-thigh level and was crushed 
twice in succession with fine forceps under anesthesia with a 
mixture of 10% ketamine and Rompun (Bayer, Leverkusen, 
Germany). After recovery, mice were sacrificed with a high 
dose of 10% ketamine, and nerves were removed, fixed with 
4% paraformaldehyde (PFA) and cryoprotected overnight. 
Frozen sections (10-μm thick) were prepared with a cryostat 
(CM3050, Leica, Solms, Germany) or nerves were teased 
under a stereomicroscope. The teased nerve fibers were 
mounted on a slide, dried, and maintained at −70
oC.
Sciatic nerve explants culture
Sciatic nerve explants were cultured for in vitro Wallerian 
degeneration as previously reported [6]. Sciatic nerves 
from adult mice were removed, and connective tissues 
surrounding the nerves were carefully detached in calcium/
magnesium-free Hank’s buffered solution. Sciatic nerves were 
longitudinally cut into two or three nerve explants and were 
then cut into small, 3-mm long explants. These explants were 
maintained in Dulbecco’s modified Eagle’s medium (Sigma-
Aldrich, St. Louis, MO, USA) containing 10% heat-inactivated 
fetal bovine serum at 37
oC with 5% CO2 for the indicated 
time. After culture, the nerve explants were fixed with PFA for 
6-12 hours and teased into a single or several nerve fibers.
A myelin ovoid was defined as an ovoid fragmented myelin 
sheath that was completely separated from the adjacent myelin 
sheath. The number of myelin ovoids was counted in medium 
to large sized-teased nerve fibers that were approximately 200 
μm in length (≤100 nerve fibers/group) under an Axiophot 
upright microscope equipped with differential interference 
contrast (DIC) filters (Carl Zeiss, Oberkochen, Germany). 
Western blot analysis
For Western blot analysis, the distal side of the injured 
nerves was harvested and lysed in modified radioimmune 
precipitation assay lysis buffer (150 mM NaCl, 1% Nonidet 
P-40, 1 mM ethylenediaminetetraacetic acid, 0.5% deoxycholic 
acid, 2 μg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 
5 mM benzamidine, 1 mM sodium orthovanadate, and 1× 
protease inhibitor cocktail [Roche, Indianapolis, IN, USA]). 
The lysates were centrifuged at 8,000 ×g for 10 minutes at 4
oC, 
and the supernatant was collected. The protein concentration 
in each sample was analyzed by the Bradford method. Protein 
(25-35 μg) was separated by 8% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and then transferred 
onto a nitrocellulose membrane (Amersham Biosciences, 
Piscataway, NJ, USA). After blocking with 0.1% Tween-20 
and 5% nonfat dry milk in Tris-buffered saline (TBS, 25 mM 
Tris-HCl pH 7.5, 140 mM NaCl) at room temperature for 1 Lysosome regulates p75 nerve growth factor receptor
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hour, the membrane was incubated with primary antibodies 
(1 : 500-1,000) in TBS with Tween 20 (TBST) containing 
2% nonfat dry milk at 4°C overnight. After three 15-minute 
washes with TBST, the membranes were incubated with a 
horseradish peroxidase-conjugated secondary antibody (1 : 
3,000) for 1 hour at room temperature. Signals were detected 
using the Enhanced Chemiluminescence System (Amersham 
Biosciences). X-ray film was scanned using an HP scanner 
and analyzed with the LAS image analysis system for 
quantification (Fujifilm, Tokyo, Japan). 
Immunofluorescent staining
The teased nerve fibers on slides were blocked with 
phosphate buffered saline (PBS) containing 0.2% Triton 
X-100 and 2% bovine serum albumin for 1 hour for 
immunofluorescent staining. The nerve fibers were then 
incubated with primary antibody (1 : 1,000) for 16 hours at 
4
oC and washed three times with PBS. Next, the slides were 
incubated with Cy3- or Alexa 488-conjugated secondary 
antibody (1 : 800, Jackson Immunoresearch Laboratories, 
West Grove, PA, USA) for 3 hours at room temperature. The 
sections were then washed three times with PBS, and then 
mounted with coverslips on glass slides using a mounting 
medium (Gelmount, Biomeda Co., Foster City, CA, USA) 
and viewed using a laser confocal microscope (LSM510, Carl 
Zeiss). 
Reverse transcription-polymerase chain reaction
Total RNA was extracted from sciatic nerve explants 
using the Ultraspec RNA Isolation Kit (Biotecx, Houston, 
TX, USA) for the reverse transcription-polymerase 
chain reaction (RT-PCR). For cDNA synthesis, 500 
ng of total RNA was used with ready-to-go-your-
prime first strand beads (Amersham Biosciences) using 
oligo(dT) primers, as indicated by the manufacturer. The 
following primers were used to detect p75NGFR and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
mRNA in the sciatic nerve. p75NGFR forward primer, 
5'-CCCTCAAGGGTGATGGCAACCTCT-3' and reverse 
primer, 5'-TGTCAGCTCTCTGGATGCGTCGC-3'; GAPDH 
forward primer, 5'-TGCCGCCTGGAGAAACCTGC-3' and 
reverse primer, 5'-TGAGAGCAATGCCAGCCCCA-3'. After 
an initial step at 94
oC for 5 minutes, 28 cycling conditions 
were carried out at 94
oC for 1 minute, 57
oC for 45 seconds, 
and 72
oC for 1 minute before a final extension period of 5 
minutes at 72
oC. To check that the product was accumulating 
in a linear manner, 1/10 of each reaction was electrophoresed 
at five cycle intervals on a 1.5% agarose gel stained with 
ethidium bromide.
TNF-α knockout mice
TNF-α knockout mice were obtained from the Jackson 
Laboratory (Bar Harbor, ME, USA). Genomic DNA from 
the mouse tail was used for PCR genotyping analysis. The 
primers were as follows: TNF-α common forward primer, 
5'-TAGCCAGGAGGGAGAACAGA-3'; TNF-α wild-type 
reverse primer, 5'-AGTGCCTCTTCTGCCAGTTC-3'; TNF-α 
mutant reverse primer, 5'-CGTTGGCTACCCGTGATATT-3'. 
The PCR cycling conditions were 94
oC for 3 minutes, followed 
by 35 cycles of 94
oC for 30 seconds, 62
oC for 1 minute, 72
oC 
for 1 minute, and a final extension step at 72
oC for 2 minutes.
 
Statistical analysis 
Differences in the means between groups were statistically 
assessed using an analysis of variance followed by the 
Bonferroni post-hoc test. Differences were considered 




Transient lysosomal activation in Schwann cells after 
nerve injury
We previously showed that LAMP1 expression increases 
in sciatic nerves following injury using Western blot analysis 
[6]. In the present study, we examined the localization of 
lysosomes in Schwann cells using double immunostaining 
against LAMP1 and S100 (a Schwann cell marker) (Fig. 
1). Confocal laser microscopy showed that little LAMP1 
immunoreactivity was localized to perinuclear areas in 
control teased nerve fibers (Fig. 1A). At 3 days after axotomy, 
the distal regions of the injured sciatic nerves showed intense 
LAMP1 staining in the internodal areas. LAMP1 staining was 
colocalized with S100 staining, indicating that early LAMP1 
induction originated from Schwann cells (Fig. 1B). At 3 days 
after injury, the degenerating myelin ovoids were surrounded 
by intense LAMP1 staining (Fig. 1B), suggesting a possible 
role for lysosomes in myelin degradation. Thus, we compared 
the immunofluorescent staining of myelin basic protein 
(MBP, as a myelin marker) and LAMP1. Immunofluorescent 
staining against MBP revealed that the extent of myelin Anat Cell Biol 2011;44:41-49 Junyang Jung, et al 44
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degradation was heterogeneous 3 days after injury. MBP 
staining showed clump-like patterns within myelin ovoids, 
which were surrounded by LAMP1 staining. In contrast, 
regions with relatively intact MBP staining in the myelin 
sheath were devoid of a LAMP1 signal (Fig. 1B), suggesting a 
role for lysosomes in myelin degradation. 
The increase in the number of lysosomes as demonstrated 
by LAMP1 staining in Schwann cells was transient. At 7 days 
after injury, LAMP1 immunoreactivity was significantly 
downregulated in the internodal areas where myelin debris 
had been completely removed (asterisks in Fig. 1C). Instead, 
many macrophages, which were labeled with an antibody to 
CD68, were observed within or outside endoneurial tubes 
that expressed high levels of LAMP1 (arrows in Fig. 1C). At 
3 weeks after injury, the remyelinated fibers, as demonstrated 
by laminin or MBP immunostaining, were negative for 
LAMP1 staining (Fig. 1D). However, strong LAMP1-positive 
macrophages were still found outside these remyelinating 
Fig. 1. Transient induction of lysosomal 
associated membrane protein 1 (LAMP1) 
in demyelinating Schwann cells. (A) 
LAMP1 was localized in perinuclear 
areas (arrows) in control sciatic nerves. 
(B) Sciatic nerve crush-induced 
LAMP1 in demyelinating Schwann 
cells, particularly around myelin ovoids 
3 days (3d) after injury. The upper 
panels are double staining against 
LAMP1 and S100 (arrow), and the 
lower panels are double staining against 
LAMP1 and myelin basic protein 
(MBP). Asterisk in the middle panels 
are myelin ovoids demonstrated by 
differential interference microscopy. 
Asterisks in the lower panels are MBP-
positive clumps surrounded by LAMP1 
immunoreactivity. Arrows indicate a 
LAMP1-negative intact myelin sheath. 
(C) Downregulation of LAMP1 in 
demyelinating Schwann cells 7 days 
(7d) after injury (asterisks). Arrows 
indicate LAMP1 and CD68-positive 
macrophages. Macrophages were found 
inside or outside the endoneurial tube 
labeled with antibody against laminin 
(LAM). (D) Three weeks (3W) after 
injury, remyelinating Schwann cells 
(labeled with MBP or LAM) were 
devoid of LAMP1 staining, whereas 
many LAMP1-positive macrophages 
were still present around remyelinating 
Schwann cells. DIC, differential 
interference contrast. Scale bars=100 
μm.Lysosome regulates p75 nerve growth factor receptor
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fibers. Thus, it may be possible that lysosomal activation in 
Schwann cells is transient and that macrophages participate 
in the lysosomal degradation of myelin during the late phase 
of Wallerian degeneration. 
Lysosomal acidification is required for demyelination
Lysosomal activation may play a role in the demyelination 
process. Many lysosomal enzymes rely on an acidic pH 
for optimal activation. We examined whether lysosomal 
acidification inhibitors affected demyelination using ex vivo 
explants cultures, which have been previously established as a 
useful in vitro model for Wallerian degeneration [6]. First, the 
effect of lysosomal acidification inhibitors on myelin ovoid 
formation, which is an initial sign of demyelination, was 
examined under DIC microscopy (Fig. 2A, B). Bafilomycin 
A (BFA) and NH4Cl significantly inhibited myelin ovoid 
formation at 3 days of culture (3DIV). Chloroquine (CQ) has 
been used as a lysosomotropic amine to disrupt lysosomal 
membrane integrity, thereby inhibiting lysosomal activity [23]. 
Thus, we tested CQ to examine whether lysosomal activation 
participates in myelin ovoid formation. As shown in Fig. 2, 
myelin ovoid formation at 3DIV was prevented by CQ, which 
further suggests that lysosomal acidification is essential for 
myelin ovoid formation.
Second, we examined the destruction of MBP in the 
presence or absence of lysosomal acidification inhibitors in 
explants cultures to show that myelin protein degradation is 
associated with lysosomal acidification. Western blot analyses 
showed that MBP levels were downregulated with time in 
vitro, and that BFA and NH4Cl suppressed the decrease in 
MBP at 6DIV (Fig. 2C). However, these drugs did not affect 
LAMP1 induction during in vitro Wallerian degeneration (Fig. 
2D). Thus, lysosomal acidification seems to be required for 
demyelination during Wallerian degeneration. 
Fig. 2. Lysosomal acidification is 
re quired for demyelination. (A) 
Differential interference microscopy 
of teased nerve fibers after 3 days of 
culture in vitro (3DIV). Scale bar=200 
μm. (B) Quantitative result showing 
myelin ovoid index. (C, D) Western 
blot analysis showing the levels of 
myelin basic protein (MBP) (C) 
and lysosomal associated membrane 
protein 1 (LAMP1) (D) in cultured 
nerve explants. “C” indicates uninjured 
sciatic nerves. CQ, chloroquine; BFA, 
bafilomycin A.Anat Cell Biol 2011;44:41-49 Junyang Jung, et al 46
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Lysosomal acidification is required for p75NGFR 
induction
To determine whether lysosomal acidification is necessary 
for p75NGFR induction, we immunostained teased nerve 
fibers at 3DIV in the presence or absence of lysosomal 
acidification inhibitors. The induction of p75NGFR in 
degenerating nerves was clearly observed at 3DIV, and 
we found that NH4Cl and BFA significantly prevented 
p75NGFR induction. Axonal degradation, as demonstrated 
by neurofilament staining, still occurred even in the presence 
of the drugs, thereby suggesting that lysosomal acidification 
plays no role in axonal degeneration (Fig. 3A). Western blot 
analyses also revealed that these lysosomal acidification 
inhibitors suppressed p75NGFR induction at 3DIV (Fig. 3B). 
To determine if the regulation of p75NGFR expression by 
lysosomal acidification was mediated at the transcriptional 
Fig. 3. Lysosomal acidification 
inhibitors prevent p75 nerve growth 
factor receptor (p75NGFR) induction. 
(A) Immunofluorescence microscopy 
showing p75NGFR expression in 
teased nerve fibers. Neurofilament (NF) 
staining showed extensive fragmentation 
at 3 days culture in vitro (3DIV), 
regardless of the inhibition of lysosomal 
acidification. (B) Western blot analysis 
showing the levels of p75NGFR in 
cultured nerve explants at 3DIV. (C) 
Reverse transcription-polymerase 
chain reaction experiment showing 
the induction of p75NGFR mRNA 
in cultured nerve explants at 3 days. 
(D) Western blot analysis showing the 
levels of p75NGFR in the sciatic nerves 
of tumor necrosis factor-α null mice 
(TNF-KO). (E) Immunofluorescence 
microscopy showing p75NGFR 
and lysosomal associated membrane 
pro tein 1 (LAMP1) expression in 
teased nerve fibers 3 days (3d) after 
injury. “C” indicates uninjured 
sciatic nerves. BFA, bafilomycin A; 
GAPDH, glyceraldehyde-3-phosphate 
dehydrogenase; 3d, three days after 
crush; WT, wild-type; Con, control. 
Scale bars=100 μm.Lysosome regulates p75 nerve growth factor receptor
doi: 10.5115/acb.2011.44.1.41
Anat Cell Biol 2011;44:41-49 47
www.acbjournal.com
www.acbjournal.org
level, we examined p75NGFR mRNA expression using RT-
PCR. As a result, p75NGFR mRNA expression increased 
significantly at 3DIV, and this mRNA induction was inhibited 
by BFA and NH4Cl (Fig. 3C). Taken together, these findings 
suggest that lysosomal acidification plays an important role in 
p75NGFR expression in demyelinating Schwann cells at the 
transcriptional level.
Previous reports have shown that TNF-α regulates gene 
expression in Schwann cells, including p75NGFR in vitro [18-
20, 24]. To directly test whether TNF-α is involved in injury-
induced LAMP1 and p75NGFR expression in demyelinating 
Schwann cells, we examined LAMP1 and p75NGFR induction 
in the injured sciatic nerve of TNF-α null mice using Western 
blot analyses and immunofluorescent staining (Fig. 3D, E). 
In the TNF-α null mice, p75NGFR expression increased in 
the distal stump of the injured sciatic nerve. Furthermore, 
LAMP1 induction was not significantly altered in TNF-α 
knockout mice compared to wild-type mice, suggesting that 
TNF-α does not play an important role in injury-induced 
p75NGFR and LAMP1 expression in vivo. 
Discussion
After axonal injury, Schwann cells undergoing Wallerian 
degeneration and re-express many genes that were expressed 
during embryonic development. This change in gene 
expression results in phenotypic changes that transform 
differentiated Schwann cells into premature Schwann cells, 
which is called dedifferentiation [25]. Axonal signaling has 
been suggested as a primary regulating factor for Schwann 
cell gene expression, including p75NGFR. A loss of axonal 
contact by injury results in p75NGFR induction in Schwann 
cells, and its subsequent downregulation is accompanied by 
axonal regrowth [12, 13]. Consistent with these findings, 
cultures of adult Schwann cells derived from intact nerves 
exhibit constitutive induction of p75NGFR [26]. Additionally, 
neurons suppress p75NGFR expression in Schwann cell co-
cultures [16]. Thus, it has been suggested that axonal signals 
constitutively suppress p75NGFR induction and that the 
loss of axonal signals from injury results in the induction 
of p75NGFR. However, how the depression of axonal 
signals mechanistically regulates p75NGFR expression is 
not well understood. Our data suggest, for the first time, 
that lysosomal activation may mediate an intermediate step 
between the loss of axonal signals and p75NGFR induction. 
In other words, the loss of axonal signals leads to lysosome 
activation in demyelinating Schwann cells, and, subsequently, 
Schwann cells upregulate p75NGFR. Interestingly, the 
transient activation profiles of lysosomes during Wallerian 
degeneration are consistent with the role of axonal signals in 
lysosomal activation. At 7 days after injury, LAMP1 staining 
in Schwann cells, which had finished myelin degradation, was 
markedly downregulated. Furthermore, regenerated nerve 
fibers at 2 and 3 weeks after injury did not show LAMP1 
induction. Thus, axonal signals may regulate both lysosomal 
and p75NGFR induction in Schwann cells. 
Quantitative histochemical techniques have demonstrated 
an increase in the number of lysosomes in demyelinating 
Schwann cells during Wallerian degeneration [4]. Specifically, 
these findings have revealed that the activity of several 
lysosomal enzymes, including acid proteinase, increase in 
injured nerves, and that these enzymes may participate in 
myelin degradation. The intralysosomal environment is 
maintained near pH 4.5 by membrane-bound H-ATPases, 
and BFA inhibits the H-ATPase and prevents acidification of 
lysosomes [27]. There is general agreement that lysosomal 
acidification inhibitors suppress protein degradation in 
lysosomes, because lysosomal hydrolytic enzymes are 
optimally active at an acidic pH [28]. In the present study, 
we found that the inhibition of lysosomal acidification 
suppressed demyelination. This finding was demonstrated 
by the changed MBP levels; however, no effect on axonal 
degeneration was observed. Thus, this finding suggests that 
lysosome-dependent myelin degradation may participate 
in p75NGFR induction, and that axonal degeneration may 
not be sufficient for p75NGFR induction. In accordance 
with this hypothesis, it has been previously reported that the 
occurrence of demyelination is associated with p75NGFR 
expression in many pathological conditions involving the 
peripheral nervous system. For example, immune-mediated 
and lysolecithin-induced demyelination is accompanied by 
changes in p75NGFR expression in peripheral nerves [29]. 
Patients with hereditary and tellurium-induced neuropathy 
present with demyelination and exhibit changes in 
p75NGFR expression [30, 31]. Thus, demyelination induced 
by lysosomal enzymes might be important for inducing 
p75NGFR expression. 
In contrast to several in vitro studies, which show the role 
of TNF-α in p75NGFR induction in Schwann cells, TNF-α 
knockout mice did not show an obvious difference compared 
to wild-type mice with respect to p75NGFR expression in Anat Cell Biol 2011;44:41-49 Junyang Jung, et al 48
www.acbjournal.com
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the sciatic nerves after injury. TNF-α may play a minor role 
in p75NGFR induction in demyelinating Schwann cells in 
vivo or compensation by other factors, such as lysosomal 
activation, may result in the absence of an obvious phenotype 
in TNF-α knockout mice.
In conclusion, the present study showed that lysosomal 
activation was essential for p75NGFR induction in 
demyelinating Schwann cells after peripheral nerve 
injury. Thus, regulation of lysosomal activity may provide 
an important strategy for managing Schwann cell 
dedifferentiation associated with Wallerian degeneration and 
some peripheral neuropathies.
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